ADJUVANT 5-FU AND MECCNU IMPROVES SURVIVAL FOLLOWING CURATIVE GASTRECTOMY FOR ADENOCARCINOMA

被引：0
|
作者：
CLARK, JL
BARCEWICZ, P
NAVA, HR
GOODWIN, PS
DOUGLASS, HO
机构：
[1] SURG ASSOCIATES NEW HAVEN,NEW HAVEN,CT
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT SURG ONCOL,BUFFALO,NY 14263
来源：
AMERICAN SURGEON | 1990年 / 56卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：423 / 427
页数：5
相关论文
共 50 条
  • [1] ADJUVANT CHEMOTHERAPY WITH 5-FU AND METHYL CCNU PROLONGS RECURRENCE FREE INTERVAL AND SURVIVAL FOLLOWING CURATIVE RESECTION FOR GASTRIC ADENOCARCINOMA
    LIVSTONE, EM
    STABLEIN, DM
    GASTROENTEROLOGY, 1981, 80 (05) : 1215 - 1215
  • [2] Prospective, randomized trial comparing 5-FU/LV with or without oxaliplatin as adjuvant treatment following curative resection of gastric adenocarcinoma
    Zhang, X. -L.
    Shi, H. -J.
    Cui, S. -Z.
    Tang, Y. -Q.
    Ba, M. -C.
    EJSO, 2011, 37 (06): : 466 - 472
  • [3] CONTROLLED RANDOMIZED EVALUATION OF COMBINED MODALITY THERAPY (5000 RAD, 5-FU + MECCNU) VS 5-FU + MECCNU ALONE FOR LOCALLY UNRESECTABLE GASTRIC CANCER
    SCHEIN, PS
    CHILDS, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 329 - 329
  • [4] 5-FU VS 5-FU AND MECCNU IN GASTROINTESTINAL CANCERS - PHASE-III STUDY OF SOUTHWEST ONCOLOGY GROUP
    BAKER, LH
    MATTER, R
    TALLEY, R
    VAITKEVICIUS, V
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 229 - 229
  • [5] COMPARISON OF 5-FU AND 5-FU + MECCNU FOLLOWING RESECTION OF COLORECTAL-CARCINOMA WITH NON-MEASURABLE INTRA-ABDOMINAL METASTASES (DUKES' D)
    MANSOUR, EG
    MACINTRYE, JM
    MUGGIA, FM
    ENGSTROM, PF
    CARBONE, PP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 349 - 349
  • [6] The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer
    J E M Crozier
    R F McKee
    C S McArdle
    W J Angerson
    J H Anderson
    P G Horgan
    D C McMillan
    British Journal of Cancer, 2006, 94 : 1833 - 1836
  • [7] The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer
    Crozier, J. E. M.
    McKee, R. F.
    McArdle, C. S.
    Angerson, W. J.
    Anderson, J. H.
    Horgan, P. G.
    McMillan, D. C.
    BRITISH JOURNAL OF CANCER, 2006, 94 (12) : 1833 - 1836
  • [8] TREATMENT OF METASTATIC COLON CANCER WITH 5-FU, MECCNU, BCG AND LEUCOVORIN
    TISMAN, G
    WU, SJ
    HITTLE, T
    STEVENS, T
    FOX, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 217 - 217
  • [9] ADJUVANT CHEMOTHERAPY WITH 5-FLUOROURACIL (5-FU) OR 5-FU PLUS METHYL-CCNU FOLLOWING SURGERY IN COLONIC CANCER
    DEXEUS, FA
    THIRLWELL, MP
    MACFARLANE, JK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 367 - 367
  • [10] Efficacy of adjuvant chemotherapy with 5-FU/leucovorin and 5-FU/levamisole colon cancer
    Porschen, R
    Bermann, A
    Löffler, T
    Haack, G
    Rettig, K
    Anger, Y
    Strohmeyer, G
    GASTROENTEROLOGY, 1998, 114 (04) : A664 - A664
12345